NASDAQ:CASC

(CASC) (CASC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$10.02
$10.02
50-Day Range
N/A
52-Week Range
$3.18
$10.21
Volume
N/A
Average Volume
1.09 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CASC stock logo

About (CASC) Stock (NASDAQ:CASC)

Cascadian Therapeutics, Inc., formerly Oncothyreon Inc., is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapeutic products for the treatment of cancer. The Company's clinical-stage product candidate includes ONT-380, an orally active and selective small-molecule human epidermal growth factor receptor (HER) 2 inhibitor. The Company's ONT-10 is a therapeutic vaccine targeting the Mucin 1 peptide antigen (MUC1). The Company is engaged in developing preclinical product candidates in oncology using its Checkpoint kinase 1 (Chk1) kinase inhibitor and protocell technology. The Company completed the evaluation of approximately two dosing cohorts in its Phase Ib trial of ONT-10 in combination with the anti-CD27 T-cell agonist antibody varlilumab in collaboration with other company. The Company has completed Phase I trial of ONT-380, with both dose-escalation and expansion components. The Company has initiated Phase Ib trials of ONT-380.

CASC Stock News Headlines

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Cascade Copper Corp CASC
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
China plans 100 launches into space
China's deep-space ambition
See More Headlines
Receive CASC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (CASC) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2017
Today
4/24/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:CASC
CUSIP
68232410
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Christopher S. Henney Ph.D. (Age 76)
    Chairman of the Board
  • Scott D. Myers (Age 51)
    President, Chief Executive Officer, Director
  • Julia Marie Eastland (Age 51)
    Chief Financial Officer, Vice President - Corporate Development, Secretary
  • Gary W. Christianson (Age 61)
    Chief Operating Officer
  • Scott Peterson Ph.D. (Age 54)
    Chief Scientific Officer
  • Robert W. Azelby (Age 49)
    Director
  • Gwendolyn A. Fyfe M.D. (Age 65)
    Independent Director
  • Steven P. James (Age 58)
    Independent Director
  • Ted W. Love M.D. (Age 58)
    Independent Director
  • Daniel Keith Spiegelman (Age 58)
    Independent Director

CASC Stock Analysis - Frequently Asked Questions

How were (CASC)'s earnings last quarter?

(CASC) (NASDAQ:CASC) posted its earnings results on Wednesday, November, 8th. The biopharmaceutical company reported ($0.28) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.01. During the same quarter last year, the company posted ($0.09) earnings per share.

What other stocks do shareholders of (CASC) own?
This page (NASDAQ:CASC) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners